MedQuist Holdings, the parent company of speech recognition and transcription technology provider MedQuist, has voluntarily delisted itself from the Nasdaq stock exchange.
MedQuist Holdings plans to inform the U.S. Securities and Exchange Commission on April 4 of its decision. The company anticipates that Nasdaq will suspend trading in its common stock within 10 days of its written notice, and delist the stock on April 14.
Through a series of transactions, MedQuist Holdings has increased its holdings of its outstanding common stock from 69.5% to approximately 97%.
